TSXV - Delayed Quote CAD

Perimeter Medical Imaging AI, Inc. (PINK.V)

0.7000

+0.0100

(+1.45%)

At close: April 26 at 2:21 PM EDT

Key Events

Loading Chart for PINK.V

9/21 12:03 PM

DELL

Previous Close 0.6900
Open 0.7000
Bid 0.6900 x --
Ask 0.7000 x --
Day's Range 0.7000 - 0.7100
52 Week Range 0.6700 - 2.0500
Volume 8,451
Avg. Volume 21,976
Market Cap (intraday) 45.537M
Beta (5Y Monthly) 0.97
PE Ratio (TTM) --
EPS (TTM) -0.3000
Earnings Date May 23, 2024 - May 27, 2024
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est 5.49

Perimeter Medical Imaging AI, Inc., a medical technology company, provides advanced imaging tools that address unmet medical needs. The company offers Perimeter S-Series optical coherence tomography (OCT) imaging system that delivers resolution margin visualization of excised tissue specimens in the operating room. It also develops Perimeter B-series OCT with ImgAssist artificial intelligence technology for patients undergoing breast conservation surgery. In addition, the company offers proprietary image library and consumable specimen containers to hospitals and cancer surgery centers. Perimeter Medical Imaging AI, Inc. is headquartered in Toronto, Canada.

perimetermed.com

--

Full Time Employees

December 31

Fiscal Year Ends

Sector

Medical Devices

Industry

Perimeter Medical Imaging AI Announces Webinar Featuring AI Expert, Anantha Kancherla, Discussing Trends in the Use of Machine Learning and Artificial Intelligence in Healthcare Applications

Perimeter Medical Imaging AI Announces Webinar Featuring AI Expert, Anantha Kancherla, Discussing Trends in the Use of Machine Learning and Artificial Intelligence in Healthcare Applications

Perimeter Medical Imaging AI Announces Participation at the Upcoming Annual Meeting of the American Society of Breast Surgeons (ASBrS) and Provides Corporate Updates

Perimeter Medical Imaging AI Announces Participation at the Upcoming Annual Meeting of the American Society of Breast Surgeons (ASBrS) and Provides Corporate Updates

Perimeter Medical Imaging AI Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update

Perimeter Medical Imaging AI Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update

Perimeter Medical Imaging AI Provides Corporate Update on Grant Funding Opportunities and Announces Conference Call/Webcast to Discuss Fourth Quarter and Year-End 2023 Financial Results

Perimeter Medical Imaging AI Provides Corporate Update on Grant Funding Opportunities and Announces Conference Call/Webcast to Discuss Fourth Quarter and Year-End 2023 Financial Results

Perimeter Medical Imaging AI Reports Its Proprietary Artificial Intelligence Algorithm + OCT Identified 96.8% of Positive Breast Cancer Margins in Newly Published Peer Reviewed Study

Perimeter Medical Imaging AI Reports Its Proprietary Artificial Intelligence Algorithm + OCT Identified 96.8% of Positive Breast Cancer Margins in Newly Published Peer Reviewed Study

Perimeter Medical Imaging AI Announces Publication of Peer-Reviewed Research Examining the High Rates of Re-Operations Following Breast-Conserving Surgeries and the Associated Increased Healthcare Costs

Perimeter Medical Imaging AI Announces Publication of Peer-Reviewed Research Examining the High Rates of Re-Operations Following Breast-Conserving Surgeries and the Associated Increased Healthcare Costs

Perimeter Medical Imaging AI Announces Expanded Commercial Presence within National Healthcare Provider System with Follow-On Placement of Perimeter S-Series OCT at Additional Hospital Site

Perimeter Medical Imaging AI Announces Expanded Commercial Presence within National Healthcare Provider System with Follow-On Placement of Perimeter S-Series OCT at Additional Hospital Site

Perimeter Medical Imaging AI Announces Further Commercial Expansion in North Texas with Follow-On Placement of Perimeter S-Series OCT within National Healthcare Provider System

Perimeter Medical Imaging AI Announces Further Commercial Expansion in North Texas with Follow-On Placement of Perimeter S-Series OCT within National Healthcare Provider System

Perimeter Medical Imaging AI Announces Investor Webinar Featuring Breast Surgeon KOL to Discuss Re-excision Epidemic and Potential Benefits of AI in Cancer Surgery

Perimeter Medical Imaging AI Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Perimeter Medical Imaging AI Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Perimeter Medical Imaging AI Announces Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Corporate Update

Perimeter Medical Imaging AI initiates new clinical trial site in Seattle, WA

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

S&P/TSX Composite index

.

YTD Return

PINK.V

42.62%

S&P/TSX Composite index

4.82%

1-Year Return

PINK.V

62.16%

S&P/TSX Composite index

7.48%

3-Year Return

PINK.V

81.82%

S&P/TSX Composite index

15.01%

5-Year Return

PINK.V

233.33%

S&P/TSX Composite index

32.54%

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Perimeter Medical Imaging AI, Inc.

0.7000

+1.45%

Mkt Cap CAD 45.537M

Industry Medical Devices

Hamilton Thorne Ltd.

1.3700

+0.74%

Mkt Cap CAD 209.278M

Industry Medical Devices

Quipt Home Medical Corp.

4.9800

-0.60%

Mkt Cap CAD 212.006M

Industry Medical Devices

VentriPoint Diagnostics Ltd.

0.2250

+7.14%

Mkt Cap CAD 35.285M

Industry Medical Devices

Delcath Systems, Inc.

5.30

+0.76%

Mkt Cap 134.828M

Industry Medical Devices

NovoCure Limited

12.64

+3.31%

Mkt Cap 1.36B

Industry Medical Devices

Senseonics Holdings, Inc.

0.4157

-0.60%

Mkt Cap 220.661M

Industry Medical Devices

Valuation Measures

As of 4/26/2024

Market Cap

45.54M
Enterprise Value

26.70M
Trailing P/E

--
Forward P/E

--
PEG Ratio (5yr expected)

--
Price/Sales (ttm)

81.83
Price/Book (mrq)

2.20
Enterprise Value/Revenue

66.18
Enterprise Value/EBITDA

-2.01

Financial Highlights

Profitability and Income Statement

Profit Margin

0.00%
Return on Assets (ttm)

-36.86%
Return on Equity (ttm)

-68.18%
Revenue (ttm)

644.75k
Net Income Avi to Common (ttm)

-14.04M
Diluted EPS (ttm)

-0.3000

Balance Sheet and Cash Flow

Total Cash (mrq)

13.98M
Total Debt/Equity (mrq)

1.28%
Levered Free Cash Flow (ttm)

-11.9M

Analyst Price Targets

4.00

5.49 Average

0.7000 Current

6.75 High

Earnings

Consensus EPS

PINK.V does not have Company Insights

VPT.V VentriPoint Diagnostics Ltd.

0.2250

+7.14%

YES.V CHAR Technologies Ltd.

0.4000

0.00%

UGE.V UGE International Ltd.

0.7800

0.00%

THNK.V Think Research Corporation

0.3150

0.00%

CRDL.TO Cardiol Therapeutics Inc.

2.4500

-2.00%

GSI.V Gatekeeper Systems Inc.

0.7600

+1.33%

CVX.V CEMATRIX Corporation

0.3850

-4.94%

PRN.TO Profound Medical Corp.

10.84

-3.73%

KWE.V KWESST Micro Systems Inc.

0.9500

0.00%

QUIS.V Quisitive Technology Solutions, Inc.

0.4000

+8.11%

CRRX.TO CareRx Corporation

2.4000

+0.84%

ATE.TO Antibe Therapeutics Inc.

0.2950

0.00%

EGT.V Eguana Technologies Inc.

0.0150

0.00%

NBVA.V Nubeva Technologies Ltd.

0.4050

-1.22%

VST.CN Victory Square Technologies Inc.

0.1100

0.00%

IZO.CN Izotropic Corporation

0.1400

+21.74%